Cargando…
Reversing the Psychiatric Effects of Neurodevelopmental Cannabinoid Exposure: Exploring Pharmacotherapeutic Interventions for Symptom Improvement
Neurodevelopmental exposure to psychoactive compounds in cannabis, specifically THC, is associated with a variety of long-term psychopathological outcomes. This increased risk includes a higher prevalence of schizophrenia, mood and anxiety disorders, and cognitive impairments. Clinical and pre-clini...
Autores principales: | De Felice, Marta, Laviolette, Steven R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346164/ https://www.ncbi.nlm.nih.gov/pubmed/34360626 http://dx.doi.org/10.3390/ijms22157861 |
Ejemplares similares
-
Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases
por: Darkovska-Serafimovska, Marija, et al.
Publicado: (2018) -
Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
por: Ramer, Robert, et al.
Publicado: (2022) -
Prenatal Cannabinoid Exposure: Emerging Evidence of Physiological and Neuropsychiatric Abnormalities
por: Nashed, Mina G., et al.
Publicado: (2021) -
Documentation of pharmacotherapeutic interventions of pharmacy students
por: King, Elicia D., et al.
Publicado: (2007) -
Review of NVP and HG and Early Pharmacotherapeutic Intervention
por: Clark, Shannon M., et al.
Publicado: (2012)